Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05346484
Title A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors (MAST)
Acronym MAST
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Imugene Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS


No variant requirements are available.